R. Shi
Impact in
-
- Growth Hormone and Insulin-like Growth Factors
-
- Lymphoma Diagnosis and Treatment
Papers in
-
- Bioactive Compounds and Antitumor Agents 1
- Co-authors
- Hans J. BerkelHerbert YuReinhold MunkerDavid L. LilienJanet HughesMaureen HeldmannRoy J. RandoHans Weill
- Journals
- Journal of Clinical Oncology (3 papers)British Journal of Cancer (2 papers)International Journal of Biological Macromolecules (2 papers)Mutagenesis (2 papers)Diabetes Obesity and Metabolism (1 paper)
- Partner nations
- United StatesChinaItaly
In The Last Decade
R. Shi
18 papers receiving 325 citations
Peers
Comparison fields: 5 of 76
- Endocrinology, Diabetes and Metabolism 98
- Pathology and Forensic Medicine 79
- Cancer Research 60
- Pulmonary and Respiratory Medicine 92
- Radiology, Nuclear Medicine and Imaging 59
Countries citing papers authored by R. Shi
This map shows the geographic impact of R. Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Shi more than expected).
Fields of papers citing papers by R. Shi
This network shows the impact of papers produced by R. Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Shi. The network helps show where R. Shi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside R. Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 18 | |
| 5 | Metformin improves the glucose and lipid metabolism via influencing the level of serum total bile acids in rats with streptozotocin-induced type 2 diabetes mellitus. | 2017 | 29 |
| 6 | 2017 | 2 | |
| 7 | 2016 | 1 | |
| 8 | 2013 | 7 | |
| 9 | 2011 | 4 | |
| 10 | 2010 | 14 | |
| 11 | 2009 | 1 | |
| 12 | 2006 | 1 | |
| 13 | 2004 | 71 | |
| 14 | 2001 | 114 | |
| 15 | 2001 | 8 | |
| 16 | 2001 | 15 | |
| 17 | 2001 | 36 | |
| 18 | 2000 | 4 | |
| 19 | 1995 | 5 | |
| 20 | 1995 | 1 |
About R. Shi
R. Shi is a scholar working on Toxicology, Complementary and alternative medicine, Otorhinolaryngology, Pharmacy and Molecular Medicine, having authored 21 papers that have together received 333 indexed citations. Recurring topics across this work include Occupational and environmental lung diseases (2 papers), DNA Repair Mechanisms (2 papers), Food Security and Health in Diverse Populations (2 papers), Multiple and Secondary Primary Cancers (2 papers), Cancer therapeutics and mechanisms (2 papers), Obesity, Physical Activity, Diet (2 papers), Growth Hormone and Insulin-like Growth Factors (2 papers) and Bioactive Compounds and Antitumor Agents (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (98 citations), Pathology and Forensic Medicine (79 citations), Cancer Research (60 citations), Pulmonary and Respiratory Medicine (92 citations) and Radiology, Nuclear Medicine and Imaging (59 citations). R. Shi has collaborated with scholars based in United States, China and Italy. Frequent co-authors include Hans J. Berkel, Herbert Yu, Reinhold Munker, David L. Lilien, Janet Hughes, Maureen Heldmann, Roy J. Rando, Hans Weill, Landis K. Griffeth and Alison D. McDonald. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, International Journal of Biological Macromolecules, Mutagenesis and Diabetes Obesity and Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.